三友医疗
(688085)
| 流通市值：47.03亿 | | | 总市值：52.60亿 |
| 流通股本：2.48亿 | | | 总股本：2.78亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 116,434,264.4 | 453,595,346.98 | 332,733,558.44 | 212,076,101.08 |
| 营业收入 | 116,434,264.4 | 453,595,346.98 | 332,733,558.44 | 212,076,101.08 |
| 二、营业总成本 | 98,103,543.87 | 422,864,287.61 | 308,284,008.9 | 202,059,781.86 |
| 营业成本 | 30,438,330.77 | 130,023,713.27 | 100,892,751.12 | 67,597,144.37 |
| 税金及附加 | 1,254,850.84 | 5,651,505.96 | 4,304,992.03 | 2,725,436.71 |
| 销售费用 | 35,806,440.3 | 144,542,711.05 | 104,871,178.13 | 67,384,806.12 |
| 管理费用 | 13,667,186.19 | 67,163,494.75 | 39,868,862.29 | 25,493,755.25 |
| 研发费用 | 18,097,373.58 | 84,288,436.24 | 63,964,458.87 | 43,879,618.93 |
| 财务费用 | -1,160,637.81 | -8,805,573.66 | -5,618,233.55 | -5,020,979.52 |
| 其中:利息费用 | - | 1,174,521.16 | 1,218,456.31 | 667,039.23 |
| 其中:利息收入 | - | 12,076,583.59 | 8,614,366.22 | 7,219,770.46 |
| 加:公允价值变动收益 | -9,402.74 | 4,160,756.48 | -11,262.27 | 106,345.11 |
| 加:投资收益 | -403,057.16 | 1,520,728.42 | 818,929.61 | 864,777.09 |
| 资产处置收益 | -26,768.29 | 6,434,089.72 | -1,156.75 | -1,156.68 |
| 资产减值损失(新) | -3,381,767.74 | -26,127,694.17 | -13,696,156.65 | -9,015,005.99 |
| 信用减值损失(新) | -1,124,725.24 | -1,121,874.56 | -138,604.55 | 324,719.86 |
| 其他收益 | 1,032,372.97 | 5,468,906.68 | 3,840,739.55 | 3,030,850.25 |
| 营业利润平衡项目 | 0 | 0 | 0.01 | 0 |
| 四、营业利润 | 14,417,372.33 | 21,065,971.94 | 15,262,038.49 | 5,326,848.86 |
| 加:营业外收入 | 22,648.92 | 1,831,218.59 | 1,514,989.65 | 198,945.9 |
| 减:营业外支出 | 56,293.79 | 993,829.74 | 369,487.81 | 122,779.65 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 14,383,727.46 | 21,903,360.79 | 16,407,540.33 | 5,403,015.11 |
| 减:所得税费用 | 3,790,867.71 | 9,790,634.14 | 8,217,207.56 | 4,245,537.74 |
| 六、净利润 | 10,592,859.75 | 12,112,726.65 | 8,190,332.77 | 1,157,477.37 |
| 持续经营净利润 | 10,592,859.75 | 12,112,726.65 | 8,190,332.77 | 1,157,477.37 |
| 归属于母公司股东的净利润 | 12,823,438.55 | 11,468,618.1 | 8,570,582.96 | 1,676,137.43 |
| 少数股东损益 | -2,230,578.8 | 644,108.55 | -380,250.19 | -518,660.06 |
| (一)基本每股收益 | 0.05 | 0.05 | 0.03 | 0.01 |
| (二)稀释每股收益 | 0.05 | 0.05 | 0.03 | 0.01 |
| 八、其他综合收益 | -84,241.52 | -849,901.15 | 1,705,364.4 | 792,115.17 |
| 归属于母公司股东的其他综合收益 | -62,810.48 | -624,653.22 | 1,271,519.7 | 608,684.14 |
| 九、综合收益总额 | 10,508,618.23 | 11,262,825.5 | 9,895,697.17 | 1,949,592.54 |
| 归属于母公司股东的综合收益总额 | 12,760,628.07 | 10,843,964.88 | 9,842,102.66 | 2,284,821.57 |
| 归属于少数股东的综合收益总额 | -2,252,009.84 | 418,860.62 | 53,594.51 | -335,229.03 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |